ZVRA FY 2020 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M+3.5% YoY

Gross Profit

$12M90.2% margin

Operating Income

-$6M-42.2% margin

Net Income

-$13M-96.0% margin

EPS (Diluted)

$-3.21

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$11M

Total Liabilities

$78M

Stockholders' Equity

-$66M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$13M	+3.5%
Gross Profit	$12M	$10M	+21.1%
Operating Income	-$6M	-$20M	+72.4%
Net Income	-$13M	-$25M	+48.0%